Cancer is a complex and heterogeneous disease, and RCTs alone often cannot capture the full spectrum of patient experiences and outcomes. RWE provides insights into how cancer treatments perform in diverse patient populations, including those who are often underrepresented in clinical trials, such as the elderly, those with comorbidities, and minorities. It helps bridge the gap between clinical trial results and real-world patient outcomes.
